A low-dose of the common gout drug colchicine does not appear to significantly reduce hs-CRP levels after acute MI, results of a pilot study shows. “We all know that atherosclerosis is an inflammatory disease and that inflammation plays a key role in all stages of atherosclerosis, from the initiation to development and growth of plaques ...
Ischaemic heart disease
Disappointing results for colchicine in acute MI: LoDoCo-MI
10 Aug 2019